A study of chemotherapy and radiation for cervical cancer

What we are studying

The purpose of this study is to compare the effects, good and/or bad, of giving additional chemotherapy to you after the usual treatment of chemotherapy and radiation for your cervical cancer. The standard treatment for your type of cervical cancer is cisplatin chemotherapy plus radiation. The study will determine whether adding chemotherapy with carboplatin and paclitaxel (experimental for your type of cervical cancer) to standard radiation and cisplatin chemotherapy improves survival without increasing side effects. Cisplatin, carboplatin, and paclitaxel are FDA (Food and Drug Administration) approved drugs used to treat a number of different types of cancers, however carboplatin and paclitaxel are experimental for the treatment of cervical cancer. In this study, you will receive either radiation plus cisplatin alone or radiation plus cisplatin followed by carboplatin and paclitaxel.

Who is Eligible

  • Genders:
    • Women
  • Races:
    • White
    • African American
    • Asian
    • American Indian or Alaska Native
    • Native Hawaiian or Pacific Islander
    • Other
  • All Ethnicities
  • Ages 18+

Eligibility Criteria

  • Have had a hysterectomy within the past 2 months
  • Diagnosis of cervical cancer

What is involved

  • Randomly selected to receive standard treatment for cervical cancer or standard treatment plus study drug



Contact Information

Study Coordinator
Melissa Swain, RN
[email protected]

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.